发明名称 CORRECTION FACTOR TESTING USING FREQUENT BLOOD GLUCOSE INPUT
摘要 An apparatus comprises receiving a user prompt in a blood glucose (BG) management device to start a determination of an effective correction factor, receiving sampled blood glucose data of a patient obtained during a specified time duration, including a time duration after delivery of an initial insulin correction bolus, determining the effective correction factor using the BG management device according to a determined decrease in the blood glucose level of the patient and an amount of insulin in the initial insulin correction bolus, and cancelling the determination of the effective correction factor if a blood glucose level of the patient is outside of a specified range of blood glucose levels.
申请公布号 US2016082188(A1) 申请公布日期 2016.03.24
申请号 US201514962635 申请日期 2015.12.08
申请人 Tandem Diabetes Care, Inc. 发明人 Blomquist Michael L.;Pope Rhall E.
分类号 A61M5/172;G06F19/00;A61M5/142 主分类号 A61M5/172
代理机构 代理人
主权项 1. (canceled)
地址 San Diego CA US